4-(Chloroacetyl)benzonitrile - CAS 40805-50-3
Catalog: |
BB055600 |
Product Name: |
4-(Chloroacetyl)benzonitrile |
CAS: |
40805-50-3 |
Synonyms: |
4-(2-chloroacetyl)benzonitrile; Benzonitrile, 4-(chloroacetyl)-; 4-(chloroacetyl)benzonitrile; 4-cyanophenacyl chloride; 4-(CHLOROACETYL)-BENZONITRILE; 4-(2-chloroacetyl)benzenecarbonitrile; Benzonitrile, 4-(chloroacetyl)- (9CI) |
IUPAC Name: | 4-(2-chloroacetyl)benzonitrile |
Molecular Weight: | 179.6 |
Molecular Formula: | C9H6NOCl |
Canonical SMILES: | C1=CC(=CC=C1C#N)C(=O)CCl |
InChI: | InChI=1S/C9H6ClNO/c10-5-9(12)8-3-1-7(6-11)2-4-8/h1-4H,5H2 |
InChI Key: | LDHNCFIXYHXVDN-UHFFFAOYSA-N |
Melting Point: | 92- 95 °C |
Solubility: | Chloroform (Sparingly), Methanol (Slightly) |
Appearance: | Off-White to Pale Yellow Solid |
Storage: | 4°C, Inert atmosphere |
GHS Hazard Statement: | H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral] |
Precautionary Statement: | P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P354+P338, P317, P319, P321, P330, P332+P317, P362+P364, P403+P233, P405, and P501 |
Signal Word: | Danger |
Publication Number | Title | Priority Date |
CN-110606850-A | 3-benzo [4,5] imidazo [1,2-a ] pyrazine-1-amine compound and preparation method and application thereof | 20190911 |
WO-2015087094-A1 | New arylalkenylpropargylamine derivatives exhibiting neuroprotective action for the treatment of neurodegenerative diseases | 20131210 |
CN-102285967-A | 2-arylmethylmercapto-6-(tetrahydroquinoline-1-methyl)-4-pyrimidone derivatives, and preparation method and use thereof | 20110607 |
US-2011087030-A1 | Process for the manufacture of enantiomerically pure antifungal azoles as ravuconazole and isavuconazole | 20091008 |
US-8207352-B2 | Process for the manufacture of enantiomerically pure antifungal azoles as ravuconazole and isavuconazole | 20091008 |
WO-2011042827-A1 | Process for the manufacture of enantiomerically pure antifungal azoles as ravuconazole and isavuconazole | 20091008 |
AU-2002357333-A1 | Alpha-(N-SULPHONAMIDO)ACETAMIDE DERIVATIVES AS Beta-AMYLOID INHIBITORS | 20011220 |
AU-2002357333-B2 | Alpha-(N-sulphonamido)acetamide derivatives as Beta-amyloid inhibitors | 20011220 |
CA-2471099-C | .alpha.-(n-sulphonamido)acetamide derivatives as .beta.-amyloid inhibitors | 20011220 |
EP-1465861-A1 | Alpha-(n-sulphonamido)acetamide derivatives as beta-amyloid inhibitors | 20011220 |
Complexity: | 210 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 179.0137915 |
Formal Charge: | 0 |
Heavy Atom Count: | 12 |
Hydrogen Bond Acceptor Count: | 2 |
Hydrogen Bond Donor Count: | 0 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 179.0137915 |
Rotatable Bond Count: | 2 |
Topological Polar Surface Area: | 40.9Ų |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 1.8 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Other Building Blocks
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS